We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sapna Patel

Sapna P Patel MD

Associate Professor, Director of Uveal Melanoma Program, Director of Online Media, Melanoma Medical Oncology Fellowship Program Director, The University of Texas MD Anderson Cancer Center, Houston, Texas

Dr. Patel is a Melanoma Oncologist at the University of Texas MD Anderson Cancer Center in Houston, Texas, specializing in uveal melanoma with one of the largest clinical metastatic uveal melanoma practices in the world. She has led several investigator-initiated and multi-institutional clinical trials, including studies of targeted therapy, immunotherapy, T-cell therapy, and antibody-drug conjugates for uveal melanoma. Her lab work focuses on translational research, characterizing longitudinal molecular signatures in tumor samples from patients receiving treatment. She has received intramural and extramural funding including NIH and CPRIT grants. Her goal is to develop effective therapies for metastatic disease and to identify biomarkers to predict response to treatment.

Disclosures

Dr. Patel has no relevant disclosures.